Stocks and Investing Stocks and Investing
Fri, September 8, 2017
[ 12:00 AM ] - WOPRAI
Jeremy Campbell Initiated (CBOE) at Hold and Held Target at $105 on, Sep 8th, 2017
[ 12:00 AM ] - WOPRAI
Jeremy Campbell Initiated (BEN) at Sell and Held Target at $40 on, Sep 8th, 2017
[ 12:00 AM ] - WOPRAI
Seth Weiss Upgraded (BHF) to Hold on, Sep 8th, 2017
[ 12:00 AM ] - WOPRAI
Do Kim Maintained (ALNY) at Buy with Decreased Target to $99 on, Sep 8th, 2017
[ 12:00 AM ] - WOPRAI
Betsy Graseck Maintained (AXP) at Hold with Decreased Target to $89 on, Sep 8th, 2017
[ 12:00 AM ] - WOPRAI
Myles Walton Maintained (B) at Strong Buy with Increased Target to $70 on, Sep 8th, 2017
[ 12:00 AM ] - WOPRAI
David George Upgraded (ZION) to Hold on, Sep 8th, 2017
[ 12:00 AM ] - WOPRAI
Jeff Van Sinderen Upgraded (ZUMZ) to Strong Buy on, Sep 8th, 2017
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (AES) at Hold and Held Target at $14 on, Sep 8th, 2017
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (AEP) at Hold with Increased Target to $75 on, Sep 8th, 2017
[ 12:00 AM ] - WOPRAI
Seth Weiss Downgraded (AFL) to Sell on, Sep 8th, 2017
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (AEE) at Hold with Increased Target to $59 on, Sep 8th, 2017
[ 12:00 AM ] - WOPRAI
Jeremy Campbell Initiated (VRTS) at Hold and Held Target at $113 on, Sep 8th, 2017
[ 12:00 AM ] - WOPRAI
Chris Merwin Initiated (TTWO) at Strong Buy and Held Target at $118 on, Sep 8th, 2017
[ 12:00 AM ] - WOPRAI
Elizabeth Lynn Graseck Downgraded (SYF) to Hold on, Sep 8th, 2017
[ 12:00 AM ] - WOPRAI
Kenneth Hill Initiated (TROW) at Sell and Held Target at $79 on, Sep 8th, 2017
[ 12:00 AM ] - WOPRAI
Kenneth Hill Initiated (BLK) at Buy and Held Target at $238 on, Sep 8th, 2017
[ 12:00 AM ] - WOPRAI
Robert Stevenson Initiated (UMH) at Strong Buy on, Sep 8th, 2017
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (SR) at Sell with Increased Target to $75 on, Sep 8th, 2017
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (XEL) at Hold with Increased Target to $48 on, Sep 8th, 2017
[ 12:00 AM ] - WOPRAI
George Staphos Maintained (BRC) at Sell with Increased Target to $34 on, Sep 8th, 2017
[ 12:00 AM ] - WOPRAI
Stephen Ju Maintained (BV) at Buy with Increased Target to $7 on, Sep 8th, 2017
[ 12:00 AM ] - WOPRAI
John Eade Initiated (BUD) at Strong Buy and Held Target at $136 on, Sep 8th, 2017
[ 12:00 AM ] - WOPRAI
Richard Newitter Upgraded (TFX) to Buy on, Sep 8th, 2017
[ 12:00 AM ] - WOPRAI
David Barden Maintained (CCI) at Strong Buy with Increased Target to $114 on, Sep 8th, 2017
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (CMS) at Hold with Increased Target to $50 on, Sep 8th, 2017
Thu, September 7, 2017
[ 12:00 AM ] - WOPRAI
Allison Landry Maintained (CSX) at Buy and Held Target at $20 on, Sep 7th, 2017
[ 12:00 AM ] - WOPRAI
David Lipschitz Initiated (BTU) at Hold and Held Target at $30 on, Sep 7th, 2017
[ 12:00 AM ] - WOPRAI
Aldo Mazzaferro Initiated (X) at Buy and Held Target at $31 on, Sep 7th, 2017
[ 12:00 AM ] - WOPRAI
Gena Wang Initiated (SRPT) at Hold and Held Target at $46 on, Sep 7th, 2017

Gena Wang Initiated (SRPT) at Hold and Held Target at $46 on, Sep 7th, 2017


Published on 2024-10-25 22:41:04 - WOPRAI, Gena Wang
  Print publication without navigation


Gena Wang of Barclays, Initiated "Sarepta Therapeutics, Inc." (SRPT) at Hold and Held Target at $46 on, Sep 7th, 2017.

Gena has made no other calls on SRPT in the last 4 months.



There is 1 other peer that has a rating on SRPT. Out of the 1 peers that are also analyzing SRPT, all agrees with Gena's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $33 on, Thursday, July 20th, 2017
Contributing Sources